ADCT
Price
$3.33
Change
-$0.25 (-6.96%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
331.26M
69 days until earnings call
QTTB
Price
$1.91
Change
-$0.01 (-0.52%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
23.54M
Interact to see
Advertisement

ADCT vs QTTB

Header iconADCT vs QTTB Comparison
Open Charts ADCT vs QTTBBanner chart's image
ADC Therapeutics SA
Price$3.33
Change-$0.25 (-6.96%)
Volume$3.81K
Capitalization331.26M
Q32 Bio
Price$1.91
Change-$0.01 (-0.52%)
Volume$7.31K
Capitalization23.54M
ADCT vs QTTB Comparison Chart
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. QTTB commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and QTTB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (ADCT: $3.59 vs. QTTB: $1.92)
Brand notoriety: ADCT and QTTB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 316% vs. QTTB: 54%
Market capitalization -- ADCT: $356.05M vs. QTTB: $23.42M
ADCT [@Biotechnology] is valued at $356.05M. QTTB’s [@Biotechnology] market capitalization is $23.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileQTTB’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • QTTB’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than QTTB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 5 TA indicator(s) are bullish while QTTB’s TA Score has 5 bullish TA indicator(s).

  • ADCT’s TA Score: 5 bullish, 4 bearish.
  • QTTB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, QTTB is a better buy in the short-term than ADCT.

Price Growth

ADCT (@Biotechnology) experienced а +43.60% price change this week, while QTTB (@Biotechnology) price change was +14.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.26%. For the same industry, the average monthly price growth was +5.04%, and the average quarterly price growth was -2.58%.

Reported Earning Dates

ADCT is expected to report earnings on Aug 12, 2025.

QTTB is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+6.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($331M) has a higher market cap than QTTB($23.5M). ADCT YTD gains are higher at: 80.402 vs. QTTB (-44.186). QTTB has higher annual earnings (EBITDA): -44.5M vs. ADCT (-110.43M). ADCT has more cash in the bank: 274M vs. QTTB (78M). QTTB has less debt than ADCT: QTTB (18.9M) vs ADCT (125M). ADCT has higher revenues than QTTB: ADCT (70.7M) vs QTTB (0).
ADCTQTTBADCT / QTTB
Capitalization331M23.5M1,409%
EBITDA-110.43M-44.5M248%
Gain YTD80.402-44.186-182%
P/E RatioN/AN/A-
Revenue70.7M0-
Total Cash274M78M351%
Total Debt125M18.9M661%
FUNDAMENTALS RATINGS
QTTB: Fundamental Ratings
QTTB
OUTLOOK RATING
1..100
16
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTQTTB
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 14 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGOCX34.420.19
+0.56%
NYLI WMC Enduring Capital Class C
RYLIX97.22N/A
N/A
Rydex Leisure Inv
DNINX19.62N/A
N/A
Dunham International Stock N
GSCLX28.87N/A
N/A
Goldman Sachs Large Cap Gr Insghts Svc
OTCNX72.69N/A
N/A
Invesco Discovery Large Cap R

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with QTTB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+2.28%
QTTB - ADCT
47%
Loosely correlated
+4.92%
CLRB - ADCT
44%
Loosely correlated
+5.91%
IMNM - ADCT
40%
Loosely correlated
+2.21%
VTYX - ADCT
40%
Loosely correlated
-2.45%
RGNX - ADCT
40%
Loosely correlated
-2.13%
More

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been closely correlated with CLRB. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
+4.92%
CLRB - QTTB
76%
Closely correlated
+5.91%
MESO - QTTB
51%
Loosely correlated
+1.64%
STOK - QTTB
49%
Loosely correlated
+9.99%
ADCT - QTTB
47%
Loosely correlated
+2.28%
ANAB - QTTB
43%
Loosely correlated
+7.59%
More